Pradžia › Limfoma › Ohio › Cleveland
Limfoma klinikiniai tyrimai Cleveland, OH
14 tyrimai dėl Limfoma ieško dalyvių vietose Cleveland ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Renkami dalyviai1/2 fazė
- University Hospitals Seidman Cancer Center, Cleveland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Renkami dalyviai1 fazė
- University Hospitals Cleveland Medical Center, Cleveland
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Renkami dalyviai2 fazė
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Renkami dalyviai2 fazė
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Renkami dalyviai2 fazė
- The Cleveland Clinic Foundation, Cleveland
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Renkami dalyviai3 fazė
- Research Site, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Renkami dalyviai1/2 fazė
- Cleveland Clinic, Cleveland
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Renkami dalyviai1/2 fazė
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Renkami dalyviai3 fazė
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
Renkami dalyviai1 fazė
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Renkami dalyviai1 fazė
- Cleveland Clinic, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Renkami dalyviai1/2 fazė
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Cleveland Clinic, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
Renkami dalyviai1 fazė
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Limfoma tyrimai kituose miestuose
- Houston, TX34 tyrimai
- Boston, MA33 tyrimai
- New York City, NY33 tyrimai
- Washington, DC23 tyrimai
- Baldwin Park, CA21 tyrimas
- Chicago, IL20 tyrimai
- Durham, NC17 tyrimai
- St. Louis, MO15 tyrimai
- Philadelphia, PA15 tyrimai
- Edison, NJ12 tyrimai
- Atlanta, GA12 tyrimai
- Seattle, WA12 tyrimai
Kiti tyrimai Cleveland
- Nedidelinių ląstelių plaučių vėžys43 tyrimai
- Vėžys (visų tipų)36 tyrimai
- Krūties vėžys35 tyrimai
- Prostatos vėžys34 tyrimai
- Širdies nepakankamumas33 tyrimai
- Metastatinis vėžys30 tyrimai
- Kiaušidžių vėžys30 tyrimai
- Plaučių vėžys26 tyrimai
- Storosios ir tiesiosios žarnos vėžys24 tyrimai
- Širdies ir kraujagyslių ligos22 tyrimai
- Endometrio vėžys20 tyrimai
- Ūmi mieloidinė leukemija20 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.